Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
INSR | CRKL | CRKL: Crk-like protein | 6.35E4 | Evidence | |||||
INSR | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 6.35E4 | Evidence | |||||
INSR | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 6.35E4 | Evidence | |||||
INSR | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 5.39E4 | Evidence | |||||
INSR | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 3.97E4 | Evidence | |||||
INSR | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 1.63E4 | Evidence | |||||
INSR | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 1.74E3 | Evidence | |||||
INSR | STAT3 | 200.0 | Evidence | ||||||
INSR | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 200.0 | Evidence | |||||
INSR | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 200.0 | Evidence | |||||
INSR | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 147.0 | Evidence | |||||
INSR | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 147.0 | Evidence | |||||
INSR | GRB10 | N/A | 141.0 | Evidence | |||||
INSR | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 135.0 | Evidence | |||||
INSR | SYK | SYK: Tyrosine-protein kinase SYK | 132.0 | Evidence | |||||
INSR | LYN | LYN: Tyrosine-protein kinase Lyn | 132.0 | Evidence | |||||
INSR | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 132.0 | Evidence | |||||
INSR | BMX | N/A | 125.0 | Evidence | |||||
INSR | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 110.0 | Evidence | |||||
INSR | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 101.0 | Evidence | |||||
INSR | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 101.0 | Evidence | |||||
INSR | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 89.30 | Evidence | |||||
INSR | CRK | CRK: Proto-oncogene C-crk | 85.60 | Evidence | |||||
INSR | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 80.50 | Evidence | |||||
INSR | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 80.00 | Evidence | |||||
INSR | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 80.00 | Evidence | |||||
INSR | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 80.00 | Evidence | |||||
INSR | APS | SH2B2, APS: SH2B adapter protein 2 | 80.00 | Evidence | |||||
INSR | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 80.00 | Evidence | |||||
INSR | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 79.90 | Evidence | |||||
INSR | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 72.70 | Evidence | |||||
INSR | JAK1 | 72.10 | Evidence | ||||||
INSR | VAV1 | VAV1, VAV: Proto-oncogene vav | 72.10 | Evidence | |||||
INSR | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 72.10 | Evidence | |||||
INSR | NCK2 | NCK2: Cytoplasmic protein NCK2 | 62.10 | Evidence | |||||
INSR | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 55.80 | Evidence | |||||
INSR | GRAP | GRAP: GRB2-related adapter protein | 53.20 | Evidence | |||||
INSR | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 53.20 | Evidence | |||||
INSR | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 52.50 | Evidence | |||||
INSR | HCK | N/A | 52.50 | Evidence | |||||
INSR | RIN1 | RIN1: Ras and Rab interactor 1 | 52.50 | Evidence | |||||
INSR | GNAI3 | GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha | 49.00 | Evidence | |||||
INSR | CSK | CSK: Tyrosine-protein kinase CSK | 47.30 | Evidence | |||||
INSR | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 44.10 | Evidence | |||||
INSR | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 43.60 | Evidence | |||||
INSR | EHD4 | EHD4, HCA10, FKSG7, HCA11, PAST4: EH domain-containing protein 4 | 40.60 | Evidence | |||||
INSR | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 39.10 | Evidence | |||||
INSR | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 37.80 | Evidence | |||||
INSR | ADAM33 | ADAM33, UNQ873/PRO1891: ADAM 33 precursor | 33.90 | Evidence | |||||
INSR | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 33.90 | Evidence | |||||
INSR | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 31.20 | Evidence | |||||
INSR | GNAO1 | GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 | 31.10 | Evidence | |||||
INSR | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 29.30 | Evidence | |||||
INSR | GHR | GHR: Growth hormone receptor precursor | 28.20 | Evidence | |||||
INSR | IL12RB2 | IL12RB2: Interleukin-12 receptor beta-2 chain precursor | 28.20 | Evidence | |||||
INSR | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 28.20 | Evidence | |||||
INSR | EPOR | EPOR: Erythropoietin receptor precursor | 28.20 | Evidence | |||||
INSR | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 25.3 | Evidence | |||||
INSR | KIT | KIT: Mast/stem cell growth factor receptor precursor | 25.3 | Evidence | |||||
INSR | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 24.80 | Evidence | |||||
INSR | GNAT1 | GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit | 23.20 | Evidence | |||||
INSR | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 22.90 | Evidence | |||||
INSR | IL4R | IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor | 22.90 | Evidence | |||||
INSR | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 22.90 | Evidence | |||||
INSR | LEPR | LEPR, DB, OBR: Leptin receptor precursor | 22.90 | Evidence | |||||
INSR | AP1GBP1 | AP1GBP1, SYNG: AP1 subunit gamma-binding protein 1 | 22.30 | Evidence | |||||
INSR | ROBO1 | ROBO1, DUTT1: Roundabout homolog 1 precursor | 22.20 | Evidence | |||||
INSR | PTPN1 | PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 | 22.20 | Evidence | |||||
INSR | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 22.20 | Evidence | |||||
INSR | DAB2 | DAB2, DOC2: Disabled homolog 2 | 21.60 | Evidence | |||||
INSR | PRLR | PRLR: Prolactin receptor precursor | 21.10 | Evidence | |||||
INSR | PTPRF | PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor | 20.50 | Evidence | |||||
INSR | TRPM7 | TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me | 20.50 | Evidence | |||||
INSR | GNAZ | GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha | 20.40 | Evidence | |||||
INSR | GNAT2 | GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit | 20.40 | Evidence | |||||
INSR | GNAI1 | GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit | 20.40 | Evidence | |||||
INSR | CNTN2 | CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor | 20.00 | Evidence | |||||
INSR | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 19.70 | Evidence | |||||
INSR | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 19.70 | Evidence | |||||
INSR | CCR2 | CCR2, CMKBR2: C-C chemokine receptor type 2 | 19.10 | Evidence | |||||
INSR | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 18.90 | Evidence | |||||
INSR | S100A3 | S100A3, S100E: Protein S100-A3 | 18.60 | Evidence | |||||
INSR | SPTA1 | SPTA1, SPTA: Spectrin alpha chain, erythrocyte | 18.60 | Evidence | |||||
INSR | AGTR1 | AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor | 17.60 | Evidence | |||||
INSR | MPL | MPL, TPOR: Thrombopoietin receptor precursor | 17.10 | Evidence | |||||
INSR | IFNAR1 | IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor | 17.10 | Evidence | |||||
INSR | STAM2 | STAM2: Signal transducing adapter molecule 2 | 16.60 | Evidence | |||||
INSR | IGFBP7 | IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor | 16.40 | Evidence | |||||
INSR | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 15.50 | Evidence | |||||
INSR | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 15.30 | Evidence | |||||
INSR | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 15.30 | Evidence | |||||
INSR | ITSN1 | ITSN1, ITSN, SH3D1A: Intersectin-1 | 15.10 | Evidence | |||||
INSR | SELE | SELE, ELAM1: E-selectin precursor | 15.00 | Evidence | |||||
INSR | IFNGR1 | IFNGR1: Interferon-gamma receptor alpha chain precursor | 15.00 | Evidence | |||||
INSR | HLA-DMB | HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec | 15.00 | Evidence | |||||
INSR | CD1A | CD1A: T-cell surface glycoprotein CD1a precursor | 15.00 | Evidence | |||||
INSR | MYL4 | MYL4, MLC1, PRO1957: Myosin light polypeptide 4 | 14.60 | Evidence | |||||
INSR | IRS2 | IRS2: Insulin receptor substrate 2 | 13.90 | Evidence | |||||
INSR | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 13.60 | Evidence | |||||
INSR | CD28 | CD28: T-cell-specific surface glycoprotein CD28 precursor | 13.50 | Evidence | |||||
INSR | NEDD9 | NEDD9, CASL: Enhancer of filamentation 1 | 13.50 | Evidence | |||||
INSR | LATS1 | LATS1, WARTS: Serine/threonine-protein kinase LATS1 | 13.50 | Evidence | |||||
INSR | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 13.50 | Evidence | |||||
INSR | CDC25A | CDC25A: M-phase inducer phosphatase 1 | 13.50 | Evidence | |||||
INSR | ACTN4 | ACTN4: Alpha-actinin-4 | 13.50 | Evidence | |||||
INSR | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 13.50 | Evidence | |||||
INSR | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 13.40 | Evidence | |||||
INSR | EHD1 | EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 | 13.20 | Evidence |